This page has been updated to reflect the New Rule effective January 21, 2019.
- For most studies, a full application for approval to use humans as experimental subjects (standard form) must be submitted.
- For studies that qualify for exempt status, please complete an Exempt Evaluation through COUHES Connect.
Applications are reviewed at monthly meetings by the full COUHES Committee. However, at the discretion of the Chairman, where there exists no more than minimal risk to subjects, an expedited review may be performed.
After reviewing the application, COUHES reports its decision to the responsible investigator.
- Protocols may be approved as submitted. Full Board Meeting approval is for one year and Expedited approval is for three years.
- If a protocol does not meet COUHES stated criteria for acceptance, or if an application is incomplete, COUHES may inform the investigator of suggested modifications and request revision and re-submission.
- If an investigator fails to respond within 60 days to a written request from COUHES for information or protocol changes then the application will be withdrawn. The investigator will be informed of this decision in writing. To continue the research the investigator will have to resubmit an application to COUHES.
Where the research involves collaboration with another institution(s), then COUHES requires that the principal investigator and his collaborating researcher(s) obtain approval from that institution(s) institutional review board (the COUHES equivalent), and forward copies of the approval to COUHES.
Approval is subject to continuing review. Approval must be renewed (usually annually). Once the study is completed, principal investigator must submit a final report.